BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37814378)

  • 21. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
    Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
    ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of a humanized tricellular static transwell blood-brain barrier model as a microphysiological system for drug development applications. - A case study based on the benchmark evaluations of blood-brain barrier microphysiological system.
    Nakayama-Kitamura K; Shigemoto-Mogami Y; Toyoda H; Mihara I; Moriguchi H; Naraoka H; Furihata T; Ishida S; Sato K
    Regen Ther; 2023 Mar; 22():192-202. PubMed ID: 36891355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Summary of a workshop on regulatory acceptance of (Q)SARs for human health and environmental endpoints.
    Jaworska JS; Comber M; Auer C; Van Leeuwen CJ
    Environ Health Perspect; 2003 Aug; 111(10):1358-60. PubMed ID: 12896859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.
    Stokar-Regenscheit N; Bell L; Berridge B; Rudmann D; Tagle D; Hargrove-Grimes P; Schaudien D; Hahn K; Kühnlenz J; Ashton RS; Tseng M; Reichelt M; Laing ST; Kiyota T; Chamanza R; Sura R; Tomlinson L
    Toxicol Pathol; 2024 Jun; ():1926233241253811. PubMed ID: 38888280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.
    J Manag Care Spec Pharm; 2016 Jul; 22(7):826-31. PubMed ID: 27333323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Approaches for Dissolution Similarity Assessment, Requirements, and Global Expectations.
    Abend AM; Zhang L; Fredro-Kumbaradzi E; Hoffelder T; Cohen MJ; Anand O; Delvadia P; Mandula H; Zhang Z; Kotzagiorgis E; Lum S; Pereira VG; Barker A; Lavrich D; Kraemer J; Sharp-Suarez S
    AAPS J; 2022 Mar; 24(3):50. PubMed ID: 35352186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop-Workshop Proceedings.
    Horne HN; Roscoe D; Litwack ED; Pathak A; Pandey JP; Gallagher PS; Koontz LM; Schuck RN; Lee EY; Hu YF; Beaver JA; Blumenthal GM; Philip R
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32914013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AMCP Partnership Forum: Enabling the Exchange of Clinical and Economic Information Pre-FDA Approval.
    J Manag Care Spec Pharm; 2017 Jan; 23(1):105-112. PubMed ID: 28025919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast Cancer Reconstruction: Design Criteria for a Humanized Microphysiological System.
    Frazier T; Williams C; Henderson M; Duplessis T; Rogers E; Wu X; Hamel K; Martin EC; Mohiuddin O; Shaik S; Devireddy R; Rowan BG; Hayes DJ; Gimble JM
    Tissue Eng Part A; 2021 Apr; 27(7-8):479-488. PubMed ID: 33528293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.
    Mehta M; Polli JE; Seo P; Bhoopathy S; Berginc K; Kristan K; Cook J; Dressman JB; Mandula H; Munshi U; Shanker R; Volpe DA; Gordon J; Veerasingham S; Welink J; Almeida S; Gonzalez P; Painter D; Tsang YC; Vaidyanathan J; Velagapudi R
    J Pharm Sci; 2023 Jul; 112(7):1749-1762. PubMed ID: 37142122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging microphysiological systems: a review.
    Peel S; Jackman M
    Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop.
    Khin NA; Francis G; Mulinde J; Grandinetti C; Skeete R; Yu B; Ayalew K; Cho SJ; Fisher A; Kleppinger C; Ayala R; Bonapace C; Dasgupta A; Kronstein PD; Vinter S
    Clin Pharmacol Ther; 2020 Nov; 108(5):949-963. PubMed ID: 31958142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation and biosimilar monoclonal antibodies: essential considerations towards regulatory acceptance in Europe. February 3-4, 2011, Freiburg, Germany.
    Reichert JM
    MAbs; 2011; 3(3):223-40. PubMed ID: 21487235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory forum opinion piece*: supporting the need for international harmonization of safety assessments for food flavoring substances.
    Konishi Y; Hayashi SM; Fukushima S
    Toxicol Pathol; 2014 Aug; 42(6):949-53. PubMed ID: 23881932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harnessing the power of microphysiological systems for COVID-19 research.
    Kleinstreuer N; Holmes A
    Drug Discov Today; 2021 Nov; 26(11):2496-2501. PubMed ID: 34332095
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.